Gross Profit Trends Compared: Pharming Group N.V. vs Supernus Pharmaceuticals, Inc.

Pharmaceutical Giants' Gross Profit Growth: 2014-2023

__timestampPharming Group N.V.Supernus Pharmaceuticals, Inc.
Wednesday, January 1, 201421595165116287000
Thursday, January 1, 20156590427136004000
Friday, January 1, 201611768542203017000
Sunday, January 1, 201792587038287023000
Monday, January 1, 2018129203843393541000
Tuesday, January 1, 2019165412447376095000
Wednesday, January 1, 2020203056430467938000
Friday, January 1, 2021169670071504714000
Saturday, January 1, 2022188060000580017000
Sunday, January 1, 2023220104000523742000
Loading chart...

In pursuit of knowledge

Gross Profit Trends in the Pharmaceutical Industry

In the ever-evolving pharmaceutical industry, understanding financial trends is crucial for investors and stakeholders. This analysis compares the gross profit trajectories of Pharming Group N.V. and Supernus Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Supernus Pharmaceuticals consistently outperformed Pharming Group, with its gross profit peaking at approximately 580% higher than its 2014 value by 2022. Meanwhile, Pharming Group saw a significant rise, with its gross profit increasing by nearly 920% from 2014 to 2023. This growth reflects strategic advancements and market positioning. Notably, both companies experienced their highest growth rates between 2016 and 2020, a period marked by increased demand for innovative treatments. As the pharmaceutical landscape continues to shift, these trends offer valuable insights into the financial health and strategic direction of these industry players.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025